Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy
Author:
Affiliation:
1. Department of Medical Oncology; St Bartholomew's Hospital; London UK
2. Department of Histopathology; St Bartholomew's Hospital; London UK
3. Department of Medical Oncology; University College London Hospital; London UK
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14947/fullpdf
Reference32 articles.
1. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group;J Clin Oncol,1997
2. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974);Daugaard;Ann Oncol,2011
3. Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy;Bower;Ann Oncol,1997
4. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors;Christian;J Clin Oncol,2003
5. GAMEC-a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours;Shamash;Br J Cancer,2007
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma;Oncogene;2022-03-18
2. Clinicopathological Features and Prognosis of Primary Mediastinal Malignant Germ Cell Tumors: A Retrospective Single-Institution Analysis;Cancer Management and Research;2021-11
3. The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG);British Journal of Cancer;2020-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3